The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International · 2026-03 · 109 (3) · 442-464
DOI: 10.1016/j.kint.2025.09.019 ↗Kurz gefasst
Leitlinie in der Zeitschrift Kidney International, 2026-03. Verfasst von Susan L Furth und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, U…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Obesity. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Obesity and chronic kidney disease (CKD) are complex diseases that are interlinked directly and indirectly. In October 2024, Kidney Disease: Improving Global Outcomes (KDIGO) held a Controversies Conference on the Relationship Between Obesity and CKD: Pathophysiology, Prognosis, and Management. The goals of the conference were to examine the most recent evidence regarding the epidemiology, pathophysiology, and treatment of obesity and CKD as well as to articulate priorities for research. A key conference theme was increasing the awareness of obesity-related CKD. Long-term, early-onset obesity and prolonged exposure to obesity carry the highest risk of developing CKD. Identifying early biomarkers of kidney dysfunction and refining assessment methods in the context of obesity could provide opportunities for preventing loss of kidney function. The foundation for managing obesity in CKD comprises modifications to diet, physical activity level, and behaviors related to both. However, these strategies can be unsuccessful in achieving or maintaining weight loss for a myriad of reasons. Pharmacotherapies, such as those including glucagon-like peptide-1 receptor agonists, are effective in weight reduction and have been shown to have kidney-protective and cardiovascular benefits. Metabolic and bariatric surgery has also demonstrated benefits in reducing obesity-related complications. Appropriateness and choice of management strategies will vary depending on age and comorbidities and may change over time. Patient-led goal setting is a foundation for dietary and physical activity interventions focusing on incremental, achievable changes toward healthy eating and an active lifestyle. Health care professionals require training to deliver these interventions and provide ongoing support with positive messaging using nonjudgmental, stigma-free language. Evaluating the optimal duration of therapy, long-term safety of novel pharmacotherapies, and therapies in the context of early and later stages of CKD is a key priority for research. Multidisciplinary collaboration is important both for optimizing patient care and for advancing research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: furths@chop.edu.
- Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
- Division of Nephrology, Department of Medicine, Koc University School of Medicine, Istanbul, Türkiye.
- Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, Minnesota, USA; Von Liebig Transplant Center, Department of Transplantation Surgery,…
- Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
- School of Exercise and Nutrition Sciences, Queensland University of Technology, Brisbane, Australia; Nutrition Research Collaborative, Royal Brisbane and Women's Hospital, Queensland, Australia.
Zitieren
APA
Furth, S. L., Colhoun, H. M., Kanbay, M., Kukla, A., Lim, L. L., MacLaughlin, H. L., Navaneethan, S. D., Shroff, R., Stenvinkel, P., Cheung, M., King, J. M., Grams, M. E., Jadoul, M., Rossing, P., & Conference Participants (2026). The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 109(3), 442-464. https://doi.org/10.1016/j.kint.2025.09.019
Vancouver
Furth SL, Colhoun HM, Kanbay M, Kukla A, Lim LL, MacLaughlin HL, et al. The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 2026;109(3):442-464. doi:10.1016/j.kint.2025.09.019
BibTeX
@article{Furth2026,
author = {Furth, Susan L and Colhoun, Helen M and Kanbay, Mehmet and Kukla, Aleksandra and Lim, Lee-Ling and MacLaughlin, Helen L and Navaneethan, Sankar D and Shroff, Rukshana and Stenvinkel, Peter and Cheung, Michael and King, Jennifer M and Grams, Morgan E and Jadoul, Michel and Rossing, Peter and Conference Participants, Conference Participants},
title = {The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference},
journal = {Kidney International},
year = {2026},
volume = {109},
number = {3},
pages = {442--464},
doi = {10.1016/j.kint.2025.09.019}
}
EUVIMED